Abstract
The term myofibrillar myopathy (MFM) is used to designate chronic progressive diseases of skeletal muscle, myocardium, and peripheral nerves with characteristic myopathologic features. These features include myofibrillar disorganization, accumulation of diverse myofibrillar degradation products, and aberrant expression of multiple proteins, including desmin, αB-crystallin, myotilin, β-amyloid precursor protein and dystrophin. 1,2⇓ Although MFM is not often a familial disease, in a small number of patients different gene mutations have been identified (table). In elegant studies, Nakano et al. have systematically characterized the clinical phenotypic and myopathologic features of this disease group and coined the term MFM 1 to include cases that had been previously described under different names, most commonly as desmin-storage myopathies 3 or desmin-related myopathies. 4 Because the basic abnormality in …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.